231 related articles for article (PubMed ID: 2518361)
21. IL-1 produced and released endogenously within human islets inhibits beta cell function.
Arnush M; Heitmeier MR; Scarim AL; Marino MH; Manning PT; Corbett JA
J Clin Invest; 1998 Aug; 102(3):516-26. PubMed ID: 9691088
[TBL] [Abstract][Full Text] [Related]
22. Cytokine-induced inhibition of insulin release from mouse pancreatic beta-cells deficient in inducible nitric oxide synthase.
Andersson AK; Flodström M; Sandler S
Biochem Biophys Res Commun; 2001 Feb; 281(2):396-403. PubMed ID: 11181061
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor-alpha and interferon-gamma inhibit insulin secretion and cause DNA damage in unweaned-rat islets. Extent of nitric oxide involvement.
Dunger A; Cunningham JM; Delaney CA; Lowe JE; Green MH; Bone AJ; Green IC
Diabetes; 1996 Feb; 45(2):183-9. PubMed ID: 8549863
[TBL] [Abstract][Full Text] [Related]
24. IFN-gamma and tumor necrosis factor-alpha. Cytotoxicity to murine islets of Langerhans.
Campbell IL; Iscaro A; Harrison LC
J Immunol; 1988 Oct; 141(7):2325-9. PubMed ID: 3139756
[TBL] [Abstract][Full Text] [Related]
25. Destruction of rat pancreatic islet beta-cells by cytokines involves the production of cytotoxic aldehydes.
Suarez-Pinzon WL; Strynadka K; Rabinovitch A
Endocrinology; 1996 Dec; 137(12):5290-6. PubMed ID: 8940348
[TBL] [Abstract][Full Text] [Related]
26. Human pancreatic islet beta-cell destruction by cytokines is independent of nitric oxide production.
Rabinovitch A; Suarez-Pinzon WL; Strynadka K; Schulz R; Lakey JR; Warnock GL; Rajotte RV
J Clin Endocrinol Metab; 1994 Oct; 79(4):1058-62. PubMed ID: 7962274
[TBL] [Abstract][Full Text] [Related]
27. Human pancreatic islet beta-cell destruction by cytokines involves oxygen free radicals and aldehyde production.
Rabinovitch A; Suarez-Pinzon WL; Strynadka K; Lakey JR; Rajotte RV
J Clin Endocrinol Metab; 1996 Sep; 81(9):3197-202. PubMed ID: 8784069
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic effects of cytokines on islet beta-cells: evidence for involvement of eicosanoids.
Rabinovitch A; Baquerizo H; Sumoski W
Endocrinology; 1990 Jan; 126(1):67-71. PubMed ID: 2104593
[TBL] [Abstract][Full Text] [Related]
29. Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice.
Bleich D; Chen S; Zipser B; Sun D; Funk CD; Nadler JL
J Clin Invest; 1999 May; 103(10):1431-6. PubMed ID: 10330425
[TBL] [Abstract][Full Text] [Related]
30. Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity.
Karlsen AE; Rønn SG; Lindberg K; Johannesen J; Galsgaard ED; Pociot F; Nielsen JH; Mandrup-Poulsen T; Nerup J; Billestrup N
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12191-6. PubMed ID: 11593036
[TBL] [Abstract][Full Text] [Related]
31. Effects of interleukin-15 on suppression of rat pancreatic islets in vitro induced by proinflammatory cytokines.
Wallström J; Andersson AK; Sandler S
Immunol Lett; 2003 Aug; 88(2):141-5. PubMed ID: 12880684
[TBL] [Abstract][Full Text] [Related]
32. Beneficial effect of 1,25 dihydroxyvitamin D3 on cytokine-treated human pancreatic islets.
Riachy R; Vandewalle B; Belaich S; Kerr-Conte J; Gmyr V; Zerimech F; d'Herbomez M; Lefebvre J; Pattou F
J Endocrinol; 2001 Apr; 169(1):161-8. PubMed ID: 11250657
[TBL] [Abstract][Full Text] [Related]
33. Recombinant human transforming growth factor beta does not inhibit the effects of interleukin-1 beta on pancreatic islet cells.
Hao W; Palmer JP
J Interferon Cytokine Res; 1995 Dec; 15(12):1075-81. PubMed ID: 8746789
[TBL] [Abstract][Full Text] [Related]
34. Intercellular adhesion molecule 1 is induced on isolated endocrine islet cells by cytokines but not by reovirus infection.
Campbell IL; Cutri A; Wilkinson D; Boyd AW; Harrison LC
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4282-6. PubMed ID: 2498883
[TBL] [Abstract][Full Text] [Related]
35. Metabolism and beta-cell function of rat pancreatic islets exposed to human interleukin-1 beta in the presence of a high glucose concentration.
Sandler S; Bendtzen K; Eizirik DL; Strandell E; Welsh M; Welsh N
Immunol Lett; 1990 Dec; 26(3):245-51. PubMed ID: 2086453
[TBL] [Abstract][Full Text] [Related]
36. Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans.
Andersen HU; Jørgensen KH; Egeberg J; Mandrup-Poulsen T; Nerup J
Diabetes; 1994 Jun; 43(6):770-7. PubMed ID: 8194662
[TBL] [Abstract][Full Text] [Related]
37. Low-dose interleukin 1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression.
Mehta VK; Hao W; Brooks-Worrell BM; Palmer JP
Eur J Endocrinol; 1994 Feb; 130(2):208-14. PubMed ID: 8130898
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic effects of cytokines on rat islets: evidence for involvement of free radicals and lipid peroxidation.
Rabinovitch A; Suarez WL; Thomas PD; Strynadka K; Simpson I
Diabetologia; 1992 May; 35(5):409-13. PubMed ID: 1521720
[TBL] [Abstract][Full Text] [Related]
39. Effects of prolonged exposure in vitro to interferon-gamma and tumour necrosis factor-alpha on nitric oxide and insulin production of rat pancreatic islets.
Sternesjö J; Bendtzen K; Sandler S
Autoimmunity; 1995; 20(3):185-90. PubMed ID: 7578879
[TBL] [Abstract][Full Text] [Related]
40. Repetitive exposure of pancreatic islets to interleukin-1 beta. An in vitro model of pre-diabetes?
Helqvist S; Zumsteg UW; Spinas GA; Palmer JP; Mandrup-Poulsen T; Egeberg J; Nerup J
Autoimmunity; 1991; 10(4):311-8. PubMed ID: 1772965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
